Overexpression of the EGFR protein has been detected in 9%–62% of human ovarian cancers [6, 36, 40, 41]; the differences in frequencies from these studies likely reflect utilization of different antibodies and cutoffs for overexpression. Here, EGFR is linked to ovarian cancer.